Overview

High Dose Inhaled Mannitol Study

Status:
Completed

Trial end date:
2009-04-01

Target enrollment:

Participant gender:

Summary

This study is to investigate the safety and tolerability of high doses of inhaled mannitol in subjects with bronchiectasis to further direct development of an improved drug delivery system.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Pharmaxis

Treatments:

Mannitol